Antonio E. Urbina, MD

Medical Director
Mount Sinai Hospital
New York, New York, United States

Disclosure(s): Gilead: Advisor/Consultant; Merck (Any division): Advisor/Consultant; VIIV: Advisor/Consultant

Presentation(s):

• 156 - A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for Switch to Two-Drug Antiretroviral Regimens in Patients with HIV

  Thursday, October 17, 2024
  2:15 PM – 2:30 PM US PT